Search results
California is joining with a New Jersey company to buy a generic opioid overdose reversal drug
San Jose Mercury News· 2 days agoCalifornia is partnering with a New Jersey-based pharmaceutical company to purchase a generic...
California is joining with a New Jersey company to buy a generic opioid overdose reversal drug
seattlepi.com· 2 days agoCalifornia is partnering with a New Jersey-based pharmaceutical company to purchase a generic...
Walmart Is the Nation’s Largest Grocer. Why It Added a New Private Label Food Brand.
Barrons.com· 12 hours agoThe product line will focus on affordability, with most items priced at less than $5, and will also...
California is joining with a New Jersey company to buy a generic opioid overdose reversal drug
Seattle Times· 2 days agoCalifornia is partnering with a New Jersey-based pharmaceutical company to purchase a generic...
FDA approves Amneal's generic version of OTC Narcan (NASDAQ:AMRX)
Seeking Alpha· 7 days agoThe FDA has approved Amneal Pharmaceuticals' (AMRX) OTC Naloxone HCl nasal spray, a generic version...
California Is Joining With a New Jersey Company to Make a Generic Opioid Overdose Reversal Drug
US News & World Report· 2 days agoCalifornia will soon begin selling its own generic version of Narcan — the drug that can save someone's life during an opioid overdose — under a deal announced Monday by Democratic ...
US challenges ‘bogus’ patents on Ozempic, other drugs to spur competition
Las Vegas Review-Journal· 6 hours agoBrand-name drugmakers use patents to protect their medicines and stave off cheaper, generic...
California will supply first responders, universities with opioid overdose reversal drug for free
LA Times via Yahoo News· 1 day ago(Carolyn Cole / Los Angeles Times) California will provide first responders, universities and other...
Novo’s Blockbuster Ozempic Among FTC’s Latest Patent Targets
Bloomberg Law· 13 hours agoOzempic and Victoza are among 20 branded drugs the Federal Trade Commission is targeting as it challenges more than 300 “junk patent listings” in the FDA’s registry of approved drugs in an effort ...
AMPH- A Generic Drugmaker Looking to Expand Via Acquisition, Biosimilars Moves
MoneyShow via Yahoo Finance· 7 days agoAmphastar Pharmaceuticals Inc. (AMPH) is a generic drug company founded in 1996 that went public in 2014. Amphastar focuses on drugs that are either injected or inhaled. It ...